This company boasted to Trump about its COVID-19 vaccine. Experts are skeptical.
Theres only one catch: Inovio has never actually brought a vaccine to market.
Now, with a new pandemic raging, Inovio is working on a new vaccine: for the novel coronavirus. A flurry of positive news releases about its funding and preliminary results have sent Inovios shares up by as much as 963 percent and helped the company attract money from the government and investors. At the same time, Inovio insiders have sold stock.
But some scientists and financial analysts question the viability of I…